95.97 USD
+1.43 (+1.51%)
At close: Feb 6, 2026
95.97 USD
0 (0%)
After Hours: 2/6/2026, 8:00:02 PM
Taking everything into account, IRMD scores 7 out of 10 in our fundamental rating. IRMD was compared to 186 industry peers in the Health Care Equipment & Supplies industry. IRMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. IRMD has a correct valuation and a medium growth rate. These ratings could make IRMD a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
- IRMD had positive earnings in the past year.
- In the past year IRMD had a positive cash flow from operations.
- IRMD had positive earnings in each of the past 5 years.
- IRMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- IRMD has a Return On Assets of 18.47%. This is amongst the best in the industry. IRMD outperforms 98.92% of its industry peers.
- IRMD's Return On Equity of 21.54% is amongst the best of the industry. IRMD outperforms 94.62% of its industry peers.
- With an excellent Return On Invested Capital value of 19.30%, IRMD belongs to the best of the industry, outperforming 97.31% of the companies in the same industry.
- IRMD had an Average Return On Invested Capital over the past 3 years of 18.78%. This is significantly above the industry average of 8.80%.
- The last Return On Invested Capital (19.30%) for IRMD is above the 3 year average (18.78%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.47% | ||
| ROE | 21.54% | ||
| ROIC | 19.3% |
ROA(3y)17.74%
ROA(5y)13.28%
ROE(3y)21.21%
ROE(5y)15.76%
ROIC(3y)18.78%
ROIC(5y)N/A
1.3 Margins
- With an excellent Profit Margin value of 26.31%, IRMD belongs to the best of the industry, outperforming 96.24% of the companies in the same industry.
- In the last couple of years the Profit Margin of IRMD has remained more or less at the same level.
- IRMD's Operating Margin of 30.87% is amongst the best of the industry. IRMD outperforms 98.39% of its industry peers.
- IRMD's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 77.07%, IRMD belongs to the top of the industry, outperforming 89.78% of the companies in the same industry.
- In the last couple of years the Gross Margin of IRMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.87% | ||
| PM (TTM) | 26.31% | ||
| GM | 77.07% |
OM growth 3Y8.49%
OM growth 5Y5.96%
PM growth 3Y5.58%
PM growth 5Y0.99%
GM growth 3Y0.12%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IRMD is creating value.
- IRMD has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for IRMD has been increased compared to 5 years ago.
- There is no outstanding debt for IRMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- IRMD has an Altman-Z score of 47.72. This indicates that IRMD is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of IRMD (47.72) is better than 98.92% of its industry peers.
- IRMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 47.72 |
ROIC/WACC1.97
WACC9.78%
2.3 Liquidity
- IRMD has a Current Ratio of 6.64. This indicates that IRMD is financially healthy and has no problem in meeting its short term obligations.
- IRMD has a Current ratio of 6.64. This is amongst the best in the industry. IRMD outperforms 84.41% of its industry peers.
- IRMD has a Quick Ratio of 5.72. This indicates that IRMD is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Quick ratio value of 5.72, IRMD belongs to the best of the industry, outperforming 84.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.64 | ||
| Quick Ratio | 5.72 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 13.75% over the past year.
- Measured over the past years, IRMD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.92% on average per year.
- The Revenue has grown by 12.91% in the past year. This is quite good.
- Measured over the past years, IRMD shows a quite strong growth in Revenue. The Revenue has been growing by 13.71% on average per year.
EPS 1Y (TTM)13.75%
EPS 3Y25.74%
EPS 5Y13.92%
EPS Q2Q%9.3%
Revenue 1Y (TTM)12.91%
Revenue growth 3Y20.55%
Revenue growth 5Y13.71%
Sales Q2Q%15.69%
3.2 Future
- IRMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.26% yearly.
- The Revenue is expected to grow by 8.97% on average over the next years. This is quite good.
EPS Next Y15.29%
EPS Next 2Y14.48%
EPS Next 3Y9.26%
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y11.69%
Revenue Next 3Y8.97%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 52.73, IRMD can be considered very expensive at the moment.
- Based on the Price/Earnings ratio, IRMD is valued a bit cheaper than the industry average as 69.35% of the companies are valued more expensively.
- IRMD's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.93.
- With a Price/Forward Earnings ratio of 44.38, IRMD can be considered very expensive at the moment.
- Based on the Price/Forward Earnings ratio, IRMD is valued a bit cheaper than 68.82% of the companies in the same industry.
- IRMD's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 52.73 | ||
| Fwd PE | 44.38 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, IRMD is valued a bit cheaper than the industry average as 66.13% of the companies are valued more expensively.
- 69.89% of the companies in the same industry are more expensive than IRMD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 87.51 | ||
| EV/EBITDA | 45.07 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IRMD does not grow enough to justify the current Price/Earnings ratio.
- IRMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.45
PEG (5Y)3.79
EPS Next 2Y14.48%
EPS Next 3Y9.26%
5. Dividend
5.1 Amount
- IRMD has a yearly dividend return of 0.72%, which is pretty low.
- IRMD's Dividend Yield is rather good when compared to the industry average which is at 0.20. IRMD pays more dividend than 91.40% of the companies in the same industry.
- With a Dividend Yield of 0.72, IRMD pays less dividend than the S&P500 average, which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.72% |
5.2 History
- IRMD has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- IRMD pays out 39.59% of its income as dividend. This is a sustainable payout ratio.
DP39.59%
EPS Next 2Y14.48%
EPS Next 3Y9.26%
95.97
+1.43 (+1.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-03 2025-11-03/bmo
Earnings (Next)02-10 2026-02-10/bmo
Inst Owners57.86%
Inst Owner Change-0.45%
Ins Owners36.79%
Ins Owner Change-0.4%
Market Cap1.22B
Revenue(TTM)80.51M
Net Income(TTM)21.18M
Analysts82.5
Price Target100.98 (5.22%)
Short Float %5.64%
Short Ratio5.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.72% |
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP39.59%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.85%
Min EPS beat(2)1.27%
Max EPS beat(2)10.44%
EPS beat(4)3
Avg EPS beat(4)2.54%
Min EPS beat(4)-1.96%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)4.28%
EPS beat(12)10
Avg EPS beat(12)6.04%
EPS beat(16)14
Avg EPS beat(16)9.77%
Revenue beat(2)2
Avg Revenue beat(2)0.71%
Min Revenue beat(2)0.01%
Max Revenue beat(2)1.41%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.05%
Max Revenue beat(4)1.41%
Revenue beat(8)3
Avg Revenue beat(8)-0.25%
Revenue beat(12)6
Avg Revenue beat(12)-0.02%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)0%
PT rev (3m)32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 52.73 | ||
| Fwd PE | 44.38 | ||
| P/S | 15.16 | ||
| P/FCF | 87.51 | ||
| P/OCF | 48.81 | ||
| P/B | 12.41 | ||
| P/tB | 12.85 | ||
| EV/EBITDA | 45.07 |
EPS(TTM)1.82
EY1.9%
EPS(NY)2.16
Fwd EY2.25%
FCF(TTM)1.1
FCFY1.14%
OCF(TTM)1.97
OCFY2.05%
SpS6.33
BVpS7.73
TBVpS7.47
PEG (NY)3.45
PEG (5Y)3.79
Graham Number17.79
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.47% | ||
| ROE | 21.54% | ||
| ROCE | 24.38% | ||
| ROIC | 19.3% | ||
| ROICexc | 43.34% | ||
| ROICexgc | 46.82% | ||
| OM | 30.87% | ||
| PM (TTM) | 26.31% | ||
| GM | 77.07% | ||
| FCFM | 17.33% |
ROA(3y)17.74%
ROA(5y)13.28%
ROE(3y)21.21%
ROE(5y)15.76%
ROIC(3y)18.78%
ROIC(5y)N/A
ROICexc(3y)57.41%
ROICexc(5y)N/A
ROICexgc(3y)63.62%
ROICexgc(5y)N/A
ROCE(3y)23.73%
ROCE(5y)N/A
ROICexgc growth 3Y-6.9%
ROICexgc growth 5Y0.27%
ROICexc growth 3Y-6.89%
ROICexc growth 5Y-0.24%
OM growth 3Y8.49%
OM growth 5Y5.96%
PM growth 3Y5.58%
PM growth 5Y0.99%
GM growth 3Y0.12%
GM growth 5Y-0.04%
F-Score4
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 1128.47% | ||
| Cap/Sales | 13.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 96.82% | ||
| Profit Quality | 65.85% | ||
| Current Ratio | 6.64 | ||
| Quick Ratio | 5.72 | ||
| Altman-Z | 47.72 |
F-Score4
WACC9.78%
ROIC/WACC1.97
Cap/Depr(3y)801.75%
Cap/Depr(5y)501.1%
Cap/Sales(3y)9.26%
Cap/Sales(5y)6.31%
Profit Quality(3y)60.91%
Profit Quality(5y)134.72%
High Growth Momentum
Growth
EPS 1Y (TTM)13.75%
EPS 3Y25.74%
EPS 5Y13.92%
EPS Q2Q%9.3%
EPS Next Y15.29%
EPS Next 2Y14.48%
EPS Next 3Y9.26%
EPS Next 5YN/A
Revenue 1Y (TTM)12.91%
Revenue growth 3Y20.55%
Revenue growth 5Y13.71%
Sales Q2Q%15.69%
Revenue Next Year13.26%
Revenue Next 2Y11.69%
Revenue Next 3Y8.97%
Revenue Next 5YN/A
EBIT growth 1Y16.55%
EBIT growth 3Y30.78%
EBIT growth 5Y20.49%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y194.31%
FCF growth 3Y16.9%
FCF growth 5Y11.53%
OCF growth 1Y98.66%
OCF growth 3Y31.53%
OCF growth 5Y20.16%
IRADIMED CORP / IRMD FAQ
Can you provide the ChartMill fundamental rating for IRADIMED CORP?
ChartMill assigns a fundamental rating of 7 / 10 to IRMD.
Can you provide the valuation status for IRADIMED CORP?
ChartMill assigns a valuation rating of 4 / 10 to IRADIMED CORP (IRMD). This can be considered as Fairly Valued.
Can you provide the profitability details for IRADIMED CORP?
IRADIMED CORP (IRMD) has a profitability rating of 9 / 10.
What are the PE and PB ratios of IRADIMED CORP (IRMD) stock?
The Price/Earnings (PE) ratio for IRADIMED CORP (IRMD) is 52.73 and the Price/Book (PB) ratio is 12.41.
Can you provide the financial health for IRMD stock?
The financial health rating of IRADIMED CORP (IRMD) is 9 / 10.